Research


Markets: Can they really be tamed?

A Case for Taking Risks on Drugs for the Dying

Can Wall Street Cure Cancer?

MIT prof: To cure cancer, we need pension funds as much as VC firms

‘Quant meltdown’ dangers grow

MIT Quant Guru Andrew Lo on Market’s Meltdown: ‘August Sucks’

How The FDA Could Change The Way It Approves Drugs

Should riskier drugs be approved for lethal diseases?

Gordon Gekko, Goldman Sachs and Culture’s Role in High Finance

Managing culture with risk management techniques